S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

WINT Windtree Therapeutics Inc

5.065

0.00 (0.00%)

01 May 2024 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Windtree Therapeutics (NASDAQ:WINT)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Windtree Therapeutics Charts.

Windtree Therapeutics (NASDAQ:WINT)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Windtree Therapeutics Charts.

Windtree Therapeutics Inc News

Windtree Therapeutics Announces Reverse Stock Split
Thursday 18 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
Wednesday 17 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
Tuesday 9 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 17 February 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)

Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
Friday 2 February 2024 (3 months ago) • GlobeNewswire Inc.

Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
Thursday 1 February 2024 (3 months ago) • InvestorsHub NewsWire

Form 8-K - Current report
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

More Windtree Therapeutics Inc News Articles

S&P ASX 300 Metals and M...

Newcrest Mining

Invesco QQQ Trust Series 1

Sterling vs AUD

Australia And New Zealan...

Commonwealth Bank Of Aus...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions